reports
Dorel Reports First Quarter 2024 Results
Dorel Reports First Quarter 2024 Results Dorel Juvenile confident of continued growthDorel Home significantly reduces operating loss MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) today announced results for the first quarter ended March 31, 2024. Revenue was US$351.1 million, up 5.4%, from US$333.2 million a year ago. Net loss for the first quarter was US$17.6 million or US$0.54 per diluted share compared with US$31.5 million or US$0.97 per diluted share last year. Adjusted net loss1 was US$16.9 million or US$0.52 per diluted shares versus ...
Dorel publie ses résultats du premier trimestre 2024
Dorel publie ses résultats du premier trimestre 2024 La division Dorel Produits de puériculture est confiante de poursuivre sa croissance.La division Dorel Maison réduit considérablement ses pertes opérationnelles. MONTRÉAL, 10 mai 2024 (GLOBE NEWSWIRE) -- La société Les Industries Dorel inc. (TSX : DII.B, DII.A) a annoncé aujourd’hui les résultats de son premier trimestre clos le 31 mars 2024. Le chiffre d'affaires s'est élevé à 351,1 millions de dollars US, soit une hausse de 5,4 % par rapport aux 333,2 millions de dollars US de l'exercice précédent. La perte nette pour le prem...
Black Diamond Group Limited Announces Approval of All Resolutions at 2...
Black Diamond Group Limited Announces Approval of All Resolutions at 2024 Annual General and Special Meeting CALGARY, Alberta, May 10, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI) announced the voting results from its annual general and special meeting of shareholders held on May 9, 2024 (the “Meeting”). A total of 40,064,561 common shares, representing approximately 64.71% of Black Diamond’s issued and outstanding common shares, were represented in person or by proxy at the Meeting. The following nominees were elected as director...
Antelope Enterprise Announces Second Half and Full Year 2023 Financial...
Antelope Enterprise Announces Second Half and Full Year 2023 Financial Results AEHL Records 78% Revenue Growth in 2nd Year of Operating its Livestreaming Ecommerce Business NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, today announced its financial results for the second half and fiscal year ended December 31, 2023. Fiscal Year 2023 Summary Reve...
Melco International Development: 1 director
A director at Melco International Development bought 783,000 shares at 6.187HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
United Bank For Africa: 1 director
A director at United Bank For Africa bought 37,327,918 shares at 25.930NGN and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Awardit AB: 1 director
A director at Awardit AB sold 15,000 shares at 137.500SEK and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Chongqing Zaisheng Technology Co.Ltd: 4 directors
Four Directors at Chongqing Zaisheng Technology Co.Ltd bought/maiden bought 2,230,000 shares at between 3.300CNY and 3.340CNY. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades ...
Pop Mart International Group Limited: 1 director
A director at Pop Mart International Group Limited sold 16,000,000 shares at 35.100HKD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Elecnor S.A.: 1 director
A director at Elecnor S.A. bought 14,510 shares at 20.500EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Onex Reports First Quarter 2024 Results
Onex Reports First Quarter 2024 Results All amounts in U.S. dollars unless otherwise stated TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2024. “Onex is making progress in its plans to drive growth in shareholder value, and we were pleased to see fundraising start to gain momentum in the quarter,” said Bobby Le Blanc, Chief Executive Officer. “We continue to focus our capital deployment and resource allocation on areas where we have a proven track record and the right to compete.” ...
CI Financial Reports Financial Results for the First Quarter of 2024
TORONTO--(BUSINESS WIRE)-- . (“CI”) (TSX: CIX) today released financial results for the quarter ended March 31, 2024. “CI’s first quarter was marked by robust growth, with total assets reaching a new high of $474.2 billion, a gain of $29.4 billion for the period,” said Kurt MacAlpine, CI Chief Executive Officer. “Adjusted earnings per share1 of $0.86 was up 6.2% from the previous quarter and up 16.2% from the year-ago quarter. Meanwhile, adjusted net revenues rose 4.8% and adjusted EBITDA increased 4.0% over the previous quarter. "Corient continues to perform well, with our U.S. wealth man...
Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough...
FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been selected as the winner of the “Best Overall Mental Health Solution” award in the eighth annual MedTech Breakthrough Awards program for its IDgenetix® pharmacogenomic (PGx) test. The MedTech Breakthrough Awards honor excellence and recognize innovation, hard work and success in a range of health and medical technology categories, attracting thousands of nominations from over 18 countries across the world. “...
AMC Networks Inc. Reports First Quarter 2024 Results
AMC Networks Inc. Reports First Quarter 2024 Results NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- AMC Networks Inc. ("AMC Networks" or the "Company") (NASDAQ: AMCX) today reported financial results for the first quarter ended March 31, 2024. Chief Executive Officer Kristin Dolan said: "In the first quarter, we continued to execute on our strategic priorities, including the ongoing delivery of healthy free cash flow. As new technologies transform the way media is consumed, we continue to produce great content and make it available to viewers whenever and wherever they want to ...
Supremex Reports Voting Results From Its Annual General Meeting
Supremex Reports Voting Results From Its Annual General Meeting MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced the voting results from its Annual General Meeting of Shareholders held on Thursday May 9, 2024. Voting Results: A total of 12,874,715 common shares were voted at the meeting representing 50.79% of all outstanding shares. Shareholders voted in favour of the election of all directors’ no...
Supremex annonce le résulat des votes tenus à son assemblée générale
Supremex annonce le résulat des votes tenus à son assemblée générale MONTRÉAL, 10 mai 2024 (GLOBE NEWSWIRE) -- Supremex inc. (« Supremex » ou la « Société ») (TSX : SXP), un chef de file nord-américain dans la fabrication et la distribution d’enveloppes ainsi qu’un fournisseur de solutions d’emballage en plein essor, annonce aujourd’hui le résultat du scrutin tenu lors de son assemblée annuelle des actionnaires qui a eu lieu le jeudi 9 mai 2024. Résultat des votes : Un total de 12 874 715 actions ordinaires a été voté à l’assemblée, représentant 50,79 % de toutes les actions ordinaires ...
Humacyte First Quarter 2024 Financial Results and Business Update
Humacyte First Quarter 2024 Financial Results and Business Update -Biologics License Application (BLA) for HAV™ Accepted by FDA- -BLA Granted Priority Review for Vascular Trauma Indication; PDUFA date set for August 10, 2024- -Raised approximately $43 million in net proceeds from public offering of common stock- -Conference call and live webcast at 8:00 a.m. ET today- DURHAM, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial s...
ESGL Holdings Limited Reports Full Year 2023 Results
ESGL Holdings Limited Reports Full Year 2023 Results Revenues increase by +23.5% to $6.2 million on higher waste volumes +4.8% gross margin expansion from 64.3% to 69.1% Company provides guidance for topline growth between +23% and +53% for 2024 SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ESGL) (“ESGL” or the “Company”), a sustainable waste solutions provider whose mission is to upcycle industrial waste into circular products using innovative technologies and renewable energy, today reported its financial and operating results for the full year 2023. Financial Results S...
Akero Therapeutics Reports First Quarter 2024 Financial Results and Pr...
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update -- Statistically significant week 96 results from the Phase 2b HARMONY study of EFX in patients with pre-cirrhotic MASH reported during the first quarter of 2024 -- -- Phase 3 SYNCHRONY Histology and SYNCHRONY Real-World studies in patients with pre-cirrhotic MASH (F2-F3) continue to enroll; SYNCHRONY Outcomes study in patients with compensated cirrhosis due to MASH (F4) on track to be initiated in second quarter of 2024 -- SOUTH SAN FRANCISCO, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Akero Ther...
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library C...
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting Poster presentation details screening approach allowing selection of candidate molecules applicable to dry eye disease and chronic ocular pain, with potential to identify therapeutic candidates with novel mechanisms of action for other ocular pathologies SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.